Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

What’s In A Name? Janssen’s Loss Of Sovriad Was Gilead’s Gain With Sovaldi

22 May 2014

• By Sue Sutter

Related Content

How <em>Sovaldi</em> Won A Broad Label: Emerging Data Swayed Reluctant FDA

19 Mar 2014

AstraZeneca's Vandetanib Approval Includes REMS With Distribution Restrictions

07 Apr 2011

Related Companies

Johnson & Johnson

Gilead Sciences, Inc.

AstraZeneca PLC

Additional Topics

United States BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.